BDBM518701 US11116764, Compound 2::US11253514, Compound 2::US11458135, Compound 2

SMILES COc1ccc2n(cc(CN3CCN(C)CC3)c2c1)S(=O)(=O)c1ccc(F)cc1

InChI Key InChIKey=PIQRFUCZSGOHKB-UHFFFAOYSA-N

Data  6 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 518701   

Target5-hydroxytryptamine receptor 6(Human)
Suven Life Sciences

US Patent
LigandPNGBDBM518701(US11253514, Compound 2 | US11116764, Compound 2 | ...)
Affinity DataKi:  4.96nMAssay Description:Table 2: Incubation conditions: Reactions were carried out in 50 mM Tris-HCl (pH 7.4) containing 10 mM MgCl2, 0.5 mM EDTA for 60 minutes at 37° C. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 6(Human)
Suven Life Sciences

US Patent
LigandPNGBDBM518701(US11253514, Compound 2 | US11116764, Compound 2 | ...)
Affinity DataKi:  4.96nMAssay Description:Example 2: Determination of Ki Value at 5-HT6 ReceptorCompound was tested at MDS pharma services and Novascreen according to the following procedures...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 6(Human)
Suven Life Sciences

US Patent
LigandPNGBDBM518701(US11253514, Compound 2 | US11116764, Compound 2 | ...)
Affinity DataKi:  4.96nMAssay Description:Compound was tested at MDS pharma services and Novascreen according to the following procedures.Materials and Methods:Receptor source: Human recombin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Suven Life Sciences

US Patent
LigandPNGBDBM518701(US11253514, Compound 2 | US11116764, Compound 2 | ...)
Affinity DataKi: >1.00E+4nMAssay Description:Table 3: Incubation conditions: Reactions were carried out in 67 mM Tris-HCl (pH 7.4) for 4 hours at 37° C. The reaction was terminated by rapid vacu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Suven Life Sciences

US Patent
LigandPNGBDBM518701(US11253514, Compound 2 | US11116764, Compound 2 | ...)
Affinity DataKi: >1.00E+4nMAssay Description:Example 3: Determination of Ki Value at 5-HT2A ReceptorCompound was tested according to the following procedures.Materials and Methods:Receptor sourc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Suven Life Sciences

US Patent
LigandPNGBDBM518701(US11253514, Compound 2 | US11116764, Compound 2 | ...)
Affinity DataKi: >1.00E+4nMAssay Description:Compound was tested according to the following procedures.Materials and Methods:Receptor source: Recombinant mammalian cellsRadioligand: [3H]-Ketanse...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
Go to US Patent